Objective: Accurate assessment of risk factors such as congenital heart disease (CHD) can aid in risk stratification of children presenting for surgery. Risk stratification is especially important in tonsillectomy AE adenoidectomy (T/A), a common pediatric procedure that is usually performed electively, but that has a high rate of adverse events. In this study, we examined the association of CHD with revisits after T/A.
INTRODUCTION
With improved surgical techniques and treatment options, children with congenital heart disease (CHD) are increasingly surviving to older ages. 1 An accurate assessment of risk factors in children with CHD presenting for non-cardiac surgery can aid in risk stratification of these patients. 2 Although serious perioperative adverse events related to CHD have been reported, the independent association of CHD with post-discharge outcomes remains unclear. Studies of a variety of surgical procedures performed primarily in infants and young children have generally found CHD to be associated with a greater risk of adverse postsurgical outcomes, such as increased risk of readmissions or prolonged postoperative stay. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] One previous study has described an increased risk of respiratory complications after T/A in children with CHD. 12 Yet, studies of procedures performed primarily in older children (eg, posterior spinal fusion) have typically found no association between CHD and postoperative outcomes. [13] [14] [15] [16] [17] Because common pediatric surgical procedures vary by age, the overall association of CHD with adverse outcomes in pediatric surgery can be difficult to characterize.
Notably, most recent studies examining the impact of CHD on adverse outcomes in non-cardiac surgery have used the National Surgical Quality Improvement ProgramPediatric (NSQIP-P) database. 2, 3, 5, [7] [8] [9] [10] [11] [13] [14] [15] [16] [17] While this database contains standardized information on patient comorbidities and surgical complications, only a select group of procedures are sampled for inclusion. Tonsillectomy with or without adenoidectomy (T/A), for example, is a very common procedure with a high rate of revisits (7-15%), 18, 19 but this procedure is not included in the NSQIP-P database. Therefore, conclusions about risks of CHD drawn from studies using the NSQIP-P may not apply to this surgical population.
Knowledge of CHD history can influence risk stratification, preoperative assessment, and anesthetic management. A patient with CHD considered at high risk for adverse outcomes might undergo the procedure at a specialist center or require a pediatric cardiac anesthesiologist to provide perioperative care. 20, 21 Risk stratification is especially important in T/A, which is almost always
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. performed electively, thereby permitting greater flexibility in case scheduling and planned disposition, but is associated with a high rate of adverse events related to pain, bleeding, nausea/vomiting, and respiratory depression, up to and including mortality. 18, 19, 22, 23 In this study, we examined whether CHD is associated with a higher risk of unplanned revisits following T/A. We hypothesized that patients with minor or major CHD would have a higher rate of hospital readmission or emergency department (ED) visit within 30 days of T/A.
METHODS

Study Population and Data Source
This study was deemed exempt from review by the Institutional Review Board at Nationwide Children's Hospital. We used 2010 to 2014 data from the Healthcare Cost and Utilization Project (HCUP) State Inpatient Databases (SID) and State Ambulatory Surgery and Services Databases (SASD) of Florida, Georgia, Iowa, New York, and Utah. 24 Data in the SID and SASD are derived from discharge summaries and abstracts created by hospitals and other healthcare facilities for billing purposes. The SID and SASD are population-based databases that include, respectively, records of all inpatient admissions and outpatient surgeries performed at a hospital or hospital-owned facility in a state. In some states, outpatient procedures performed at nonhospital owned facilities are also included in the SASD. 24 We identified patients <18 years of age who underwent T/A at a hospital or hospital-owned facility. Patients undergoing T/A were identified by an International Classification of Diseases, 9th revision (ICD-9) code of 28.2 or 28.3 or a Current Procedural Terminology (CPT) code of 42820, 42821, 42825, or 42826. We excluded procedures performed at non-hospital owned freestanding institutions because these institutions were not consistently included in the SASD across the selected states. The primary outcome was unplanned (nonelective) hospital readmission or ED visit within 30 days following discharge.
Definitions of CHD and Other Patient Comorbidities
Patients with CHD were identified by the presence of an ICD-9 code of 745.0-746.85, 746.87-746.9, or 747.0-747.4 on the index surgery discharge record. 25 Complexity of CHD was classified as none, minor, or major, and identified by presence of minor, major, or unclassified CHD diagnoses (Table I) . 25 Patients were classified as having minor CHD if one of the minor defects was the only CHD diagnosis listed on their discharge record. Patients with more than one minor defect, a major CHD diagnosis, or any unclassified CHD diagnosis were categorized for our analysis as having major CHD. Because the SID and SASD do not explicitly specify whether CHD has been corrected, correction status was not included in the classification scheme. Based on past literature, we controlled for other comorbidities listed among the discharge diagnosis codes for the surgical encounter, including obstructive sleep apnea (ICD-9 327.23), chromosomal anomaly (ICD-9 758), congenital airway anomaly (ICD-9 748), and neuromuscular impairment (ICD-9 318, 330, 334, 335, 343, 359, 740-742, 754-756).
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Statistical Analysis
Continuous variables were expressed as a median with interquartile range (IQR) and were compared between groups (defined by presence and severity of CHD) using rank-sum tests. Categorical variables were expressed as a count with proportion and compared between groups using Chi-square tests or Fisher's exact tests, as applicable. For the primary analysis, we used multivariable mixed effects logistic regression models to evaluate the risk of unplanned revisits according to CHD presence and severity. These models included a hospital-level random intercept effect to account for the clustering of patients within hospitals. Covariates included the following characteristics at the time of surgery: age (0-3, 4-9, or 10-17), gender, insurance status (public, private, or other), ambulatory procedure, the facility location (state and whether the facility was in a rural or urban area), year of surgery, surgery type (tonsillectomy alone vs. tonsillectomy and adenoidectomy), national median household income quartile of the patient's ZIP code of residence, and the comorbidities listed above. 6, 22, 26, 27 As a secondary analysis, we stratified patients according to inpatient status and evaluated the risk of an unplanned Unclassified congenital heart defect 302 (35%) ICD-9 = International Classification of Diseases, 9 th revision *Categories Pulmonary atresia through Aortic interruption/atresia/stenosis collapsed to maintain confidentiality, due to incidence of ≤10.
hospital revisit within these subpopulations using multivariable mixed effects logistic regression.
In further analysis, we examined the incidence of common reasons for revisit within 30 days, including pain (ICD-9 = 338.18, 338.19, 338.28, 780.96, 784.00, 784.1), bleeding (ICD-9 = 784.7, 784.8, 998.1, 998.11), nausea/vomiting (ICD-9 = 787.0, 787.01, 787.02, 787.03, 787.04), fever (ICD-9 = 780.6, 780.61, 780.62), and dehydration (ICD-9 = 276.51). Rates of revisits for these reasons were compared between patients with and without CHD using Chi-square tests. Statistical analysis was performed using Stata/IC 14.2 (StataCorp, LP, College Station, TX) with two-tailed P < .05 considered statistically significant.
RESULTS
We identified 246,703 patients age < 18 years who underwent T/A in a hospital or hospital-owned facility in Florida, Georgia, Iowa, New York, or Utah in 2010 to 2014. We excluded 2105 patients missing information on length of stay. Of the remaining 244,598 patients (median age: 6 years [IQR: 4, 9]; 50% male/50% female), 431 (0.2%) had minor CHD and 427 (0.2%) had major CHD. Specific diagnoses among patients with CHD are described in Table I . Obstructive sleep apnea was a common comorbidity (23%), while chromosomal anomalies (1%), neuromuscular impairment (1%), and congenital airway anomalies (0.3%) were relatively rare. In the overall cohort, 18,383 patients (8%) had at least one revisit within 30 days of discharge. Among the 21,591 total revisits, 18,855 (87%) were ED visits and 2,736 (13%) were hospital revisits. Among the 18,383 patients with a revisit, 2714 (15%) had multiple revisits within 30 days. On bivariate analysis, 8% of patients without CHD had at least one revisit, as compared to 11% of patients with minor CHD (P = .01) and 11% of patients with major CHD (P = .003). Patient and procedural characteristics are compared according to severity of CHD in Table II . Patients with CHD were generally younger, and more often had comorbidities including obstructive sleep apnea, chromosomal anomalies, congenital airway anomalies, and neuromuscular impairment. Patients with CHD were also more likely to have public insurance, although they did not differ from patients without CHD with regard to the median household income in their ZIP code of residence. Patients with CHD were more likely to undergo inpatient procedures and less likely to undergo tonsillectomy without adenoidectomy. When examining inpatient (Table III) and outpatient (Table IV) procedures separately, in both groups patients with CHD more often had comorbidities. In the outpatient group, patients with CHD were still generally younger, but in the inpatient group, this trend only held for patients with minor CHD. Additionally, among both inpatients and outpatients, neither insurance coverage nor zip code-level median household income varied between patients with and without CHD. In multivariable analysis (Table V) , CHD severity was not associated with an increased risk of 30-day revisits (minor CHD OR = 1.1; 95% CI: 0.8, 1.5; P = .65; major CHD OR = 1.2; 95% CI: 0.9, 1.6; P = .34). When considering other comorbidities, chromosomal anomalies (OR = 1.4; 95% CI: 1.2, 1.6; P < .001), congenital airway anomalies (OR = 1.3; 95% CI: 1.03, 1.7; P = .03), and neuromuscular impairment (OR = 1.4; 95% CI: 1.2, 1.7; P < .001) were associated with an increased risk of 30-day revisits, but obstructive sleep apnea was not (OR = 1.0; 95% CI: 1.0, 1.0; P = .88). Compared to patients aged 0 to 3 years, patients aged 4 to 9 years had a decreased risk of complications (OR = 0.9; 95% CI: 0.8, 0.9; P < .001), whereas patients aged 10 to 17 years had an increased risk (OR = 1.2; 95% CI: 1.1, 1.2; P < .001). Compared to private insurance, public insurance and other coverage were associated with an increased risk of revisits. Residence in wealthier ZIP codes was associated with a decreased risk of revisits. Inpatient status and undergoing surgery in a more recent year were also associated with increased risk of 30-day revisits, while undergoing tonsillectomy without adenoidectomy was associated with increased risk. Compared to patients with procedures performed in Utah, patients who underwent procedures in the other states examined had significantly higher rates of 30-day revisits. The likelihood ratio test showed that revisit rates differed at the hospital level (χ 2 = 1629, P < .001). When patients with one unclassified CHD diagnosis were reclassified as having minor CHD, CHD severity was still not associated with an increased risk of 30-day revisits (minor CHD OR = 1.1; 95% CI: 0.8, 1.4; P = .65; major CHD OR = 1.4; 95% CI: 0.9, 2.2; P = .18). In a supplemental analysis of 198,057 patients treated in New York, Florida, Georgia, and Iowa who also had available data on race/ethnicity, we found that, after adjustment for all patient and procedural characteristics previously described, as compared to non-Hispanic white patients, black patients (OR = 1.0; 95% CI: 1.0, 1.0; P = .91) or Hispanic patients (OR = 1.0; 1.0, 1.1; P = .17) did not have a change in revisit risk. However, patients of other race/ethnicity (OR = 0.9; 95% CI: 0.8, 0.96; P = .001) had a lower revisit risk.
When patients were stratified according to inpatient status (Table VI) , CHD severity was still not associated with an increased risk of 30-day revisits for either inpatients (minor CHD OR = 0.8; 95% CI: 0.4, 1.4; P = .44; major CHD OR = 1.5; 95% CI: 0.9, 2.4; P = .15) or outpatients (minor CHD OR = 1.3; 95% CI: 0.9, 1.8; P = .22; major CHD OR = 1.0; 95% CI: 0.7, 1.5; P = .99). Compared to patients age 0 to 3, patients age 4 to 9 years still had a decreased risk of revisits in the outpatient population, but not in the inpatient population; patients age 10 to 17 still had an increased risk of revisits in both groups. Median household income quartile and year of surgery were still associated with revisits in the outpatient population, but not in the inpatient population. Neuromuscular impairment was only associated with revisits in the inpatient population, while congenital airway anomaly was no longer associated with revisit risk in either subpopulation.
Reasons for revisits are summarized according to the presence of CHD in Table VII. In the overall cohort, reasons for revisit included bleeding (23%), dehydration (20%), pain (18%), fever (12%), and nausea (11%). Bleeding was a more common reason for patients without CHD (23%) than for patients with CHD (14%; P = .03). Patients with CHD were more likely to return for an unplanned visit for reasons other than bleeding, dehydration, pain, nausea, or fever (47%) compared to patients without CHD (34%; P = .004). Among patients with CHD who revisited for other reasons, 25 (45%) revisits were potentially related to the patient's CHD.
DISCUSSION
Proposed risk scores for pediatric surgery have specifically included CHD as a marker of increased risk for adverse outcomes. [28] [29] [30] However, the association between CHD and outcomes such as unplanned revisits may vary by procedure and patient population. We have evaluated the association of CHD with revisits after T/A, a common pediatric procedure with a high rate of revisits that has been excluded from many past studies exploring the contribution of CHD to adverse postoperative outcomes. Our findings suggest that neither minor nor major CHD are independently associated with an increased risk of hospital readmissions or ED visits among children undergoing T/A. This finding suggests that characteristics other than CHD may be more useful for predicting the risk of revisit following T/A. In particular, toddler or adolescent age group, non-cardiac comorbidities (such as chromosomal anomalies, congenital airway anomalies, or neuromuscular impairment), procedural characteristics (such as undergoing tonsillectomy with adenoidectomy), and low socioeconomic status (use of public insurance or low median household income in the ZIP code of residence) may be better predictors of revisit risk.
One previous study has described an increased risk of respiratory complications after T/A in children with CHD. 3 However, considering a broader outcome of all unplanned revisits, we did not find that CHD independently contributed to revisit risk after this procedure. Our findings add to a previous study which found that ambulatory procedures can be safely performed in children with CHD with a relatively low rate of unanticipated hospital admissions immediately following surgery. 31 Our results are also similar to prior studies reporting no excess risk of postoperative complications due to CHD, which have explored procedures other than T/A using the NSQIP-P registry. [13] [14] [15] [16] [17] In line with these studies, our analytic sample included a population of relatively older children, with a median age of 6 years. Meanwhile, the association of CHD with revisit risk appears strongest in studies that focus on younger children. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] Although our study found no excess revisit risk due to CHD, it is important to note that pediatric health care providers typically take additional precautions when treating a patient with known CHD. Institutional practices may include specific algorithms for treating patients known to have CHD, and the success of current practices at mitigating risk could account for the lack of association between CHD and unplanned revisits. As T/A is primarily an elective procedure, institutions are able to plan appropriate accommodations for patients with CHD. For example, our institution previously reported our practice of scheduling patients with CHD to undergo T/A in the main operating rooms as opposed to the ambulatory surgery center. 32 The overall revisit rate in our study was 8%, which falls within the range of revisit rates reported by previous studies (7-15%). 18, 19 When examining reasons for revisits, patients with CHD were less likely than patients without CHD to have revisits due to bleeding, but similarly likely to have revisits due to pain, nausea/vomiting, dehydration, or fever. Patients with CHD also had fewer overall revisits attributed to one of these causes, a significant proportion of which may have been related to their cardiac comorbidity. Despite the differences in reasons for revisit, the overall rate of unplanned revisits did not differ by CHD presence or severity.
The conclusions from our study are subject to several limitations. First, in comparison to previous studies using the NSQIP-P database, some variables are unavailable in the HCUP state databases. This includes American Society of Anesthesiologists (ASA) status and use of inotropic support. However, even without controlling for these more granular measures of comorbidity, we found that CHD was not independently associated with an increased risk of revisits after T/A. Second, the NSQIP-P contains information on specific comorbidities identified in the patient medical record by trained raters. By contrast, when using the HCUP, comorbidities had to be identified by ICD-9 codes, which are less accurate. Because we identified CHD using ICD-9 codes listed for the index procedure, under-reporting of CHD may have limited identification of these patients. 25 As with any study using administrative data, the identification of CHD and other comorbidities was dependent on the correct entry of diagnosis codes, leading to potential misclassification error. Such misclassification could have biased the association between CHD and adverse outcomes after tonsillectomy. Additionally, because ICD-9 codes do not indicate whether CHD has been corrected, our measure of CHD severity does not adequately capture patients' functional status. Finally, this study was limited by the lack of information on specific institutional practices related to performing T/A in patients with CHD. Without this information, we can only conclude that there is no excess risk of unplanned revisits due to CHD given the institutional practices existing at the time of data collection.
CONCLUSION
In sum, our analysis of a large multi-state data set found no excess risk of 30-day revisits associated with CHD in children undergoing T/A. This provides further evidence for the safety of non-cardiac elective surgery performed in children with CHD. Furthermore, because this finding is for a common pediatric surgery not included in the NSQIP-P, these results indicate caution when generalizing risk scoring systems developed from the NSQIP-P to procedures or populations not sampled in this database. With the mix of common pediatric procedures varying by patient age, accounting for age and procedure may be important for refining predictive models for surgical risk in children. 
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